Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

• Main Authors: Dandan Zhu (Author), Yuansheng Hu (Author), Zhiwei Jiang (Author), Tuantuan Yang (Author), Kai Chu (Author), Hengming Zhang (Author), Jialei Hu (Author), Xing Meng (Author), Zhijun Tan (Author), Jingliang Wu (Author), Xiaojuan Lian (Author), Changgui Li (Author), Hongxing Pan (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Previous phase I to III clinical trials have shown that the inactivated SARS-CoV-2 vaccine namely CoronaVac has good efficacy, safety, and immunogenicity. This phase IV trial aims to evaluate the lot-to-lot consistency, immunogenicity, and safety on a commercial scale in healthy adults, which could...